These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 1016604

  • 41. Prediction of phenytoin solubility in intravenous admixtures: physicochemical theory.
    Newton DW, Kluza RB.
    Am J Hosp Pharm; 1980 Dec; 37(12):1647-51. PubMed ID: 7446539
    [Abstract] [Full Text] [Related]

  • 42. [Studies on the kinetics of nitrofurantoin (Nifurantin) in normal pregnancy, gestoses, pyelonephritis and labor (author's transl)].
    Nöschel H, Schröder S, Eichhorn KH, Peiker G.
    Pharmazie; 1982 Mar; 37(3):204-5. PubMed ID: 7100243
    [Abstract] [Full Text] [Related]

  • 43. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.
    Blagden N, de Matas M, Gavan PT, York P.
    Adv Drug Deliv Rev; 2007 Jul 30; 59(7):617-30. PubMed ID: 17597252
    [Abstract] [Full Text] [Related]

  • 44. A comparative study on the excretion and metabolic degradation of nitrofurantoin and analogues.
    Holmen-Christensen H, Andersen HO.
    Acta Pharmacol Toxicol (Copenh); 1967 Jul 30; 25():Suppl 4:50. PubMed ID: 5630945
    [No Abstract] [Full Text] [Related]

  • 45. Renal handling of nitrofurantoin in man.
    Schirmeister J, Stefani F, Willmann H, Hallauer W.
    Antimicrob Agents Chemother (Bethesda); 1965 Jul 30; 5():223-6. PubMed ID: 5883431
    [No Abstract] [Full Text] [Related]

  • 46. How crowded is the cytoplasm?
    Fulton AB.
    Cell; 1982 Sep 30; 30(2):345-7. PubMed ID: 6754085
    [No Abstract] [Full Text] [Related]

  • 47. Bioavailability studies of acetaminophen and nitrofurantoin.
    Albert KS, Sedman AJ, Wilkinson P, Stoll RG, Murray WJ, Wagner JG.
    J Clin Pharmacol; 1974 Sep 30; 14(5-6):264-70. PubMed ID: 4829520
    [No Abstract] [Full Text] [Related]

  • 48. Intermediate excitons in molecular crystals: a study of the excited states of crystalline iodine.
    Hillier IH, Rice SA.
    J Chem Phys; 1967 Jul 15; 47(2):498-508. PubMed ID: 6065460
    [No Abstract] [Full Text] [Related]

  • 49. Nitrofurantoin is highly bound to plasma protein.
    Männistö PT, Lamminsivu U.
    J Antimicrob Chemother; 1982 Apr 15; 9(4):327-8. PubMed ID: 7085535
    [No Abstract] [Full Text] [Related]

  • 50. [Effects of grinding on the transition of the polymorphic modification phase of sulfamethoxydiazine].
    Giordano F, Bettinetti GP, Caramella C, Conte U.
    Boll Chim Farm; 1977 Jul 15; 116(7):433-8. PubMed ID: 901646
    [No Abstract] [Full Text] [Related]

  • 51. Diffraction methods for biological macromolecules. Treatment and manipulation of crystals.
    Rayment I.
    Methods Enzymol; 1985 Jul 15; 114():136-40. PubMed ID: 4079760
    [No Abstract] [Full Text] [Related]

  • 52. [Nitrofurantoin: dimensions of crystals and biologic availability].
    Borsa M, Bulletti GM, Zoni G.
    Boll Chim Farm; 1976 Jul 15; 115(7):483-8. PubMed ID: 1016604
    [No Abstract] [Full Text] [Related]

  • 53. [Biologic availability of various formulas of nitrofurantoin in tablets].
    Frigerio G, Venier A.
    Boll Chim Farm; 1973 Jul 15; 112(6):416-21. PubMed ID: 4767643
    [No Abstract] [Full Text] [Related]

  • 54. In vivo/in vitro correlation regarding nitrofurantoin tablets.
    Munoz Carnago E, Gonzales Porto E.
    Pharmazie; 1986 Apr 15; 41(4):290-1. PubMed ID: 3725877
    [No Abstract] [Full Text] [Related]

  • 55. Clinical bioavaiability of nitrofurantoin--a case of bioinequivalence.
    DiSanto AR, Chodos DJ, Phillips JP, DeSante KA, Stoll RG.
    Int J Clin Pharmacol Biopharm; 1976 Apr 15; 13(3):220-7. PubMed ID: 950266
    [Abstract] [Full Text] [Related]

  • 56. [X-ray analysis of tRNA crystals].
    Tsuboi M, Iitaka Y, Morikawa K, Nishimura Y.
    Tanpakushitsu Kakusan Koso; 1973 Jan 15; 18(1):47-52. PubMed ID: 4567926
    [No Abstract] [Full Text] [Related]

  • 57. [Nitrofurantoin: dimensions of crystals and biologic availability].
    Borsa M, Bulletti GM, Zoni G.
    Boll Chim Farm; 1976 Jul 15; 115(7):483-8. PubMed ID: 1016604
    [No Abstract] [Full Text] [Related]

  • 58. [Biologic availability of various formulas of nitrofurantoin in tablets].
    Frigerio G, Venier A.
    Boll Chim Farm; 1973 Jul 15; 112(6):416-21. PubMed ID: 4767643
    [No Abstract] [Full Text] [Related]

  • 59. In vivo/in vitro correlation regarding nitrofurantoin tablets.
    Munoz Carnago E, Gonzales Porto E.
    Pharmazie; 1986 Apr 15; 41(4):290-1. PubMed ID: 3725877
    [No Abstract] [Full Text] [Related]

  • 60. Clinical bioavaiability of nitrofurantoin--a case of bioinequivalence.
    DiSanto AR, Chodos DJ, Phillips JP, DeSante KA, Stoll RG.
    Int J Clin Pharmacol Biopharm; 1976 Apr 15; 13(3):220-7. PubMed ID: 950266
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.